Telemedicine Can Be an Effective Tool for Allergists

Share this content:
Telemedicine Can Be an Effective Tool for Allergists
Telemedicine Can Be an Effective Tool for Allergists

WEDNESDAY, Jan. 31, 2018 (HealthDay News) -- The use of telemedicine is increasing and can offer benefits in allergy and immunology practice, according to a position statement published in the December issue of the Annals of Allergy, Asthma & Immunology.

Tania Elliott, M.D., from the New York University Medical Center in New York City, and colleagues discuss the increasing use of telemedicine services and technology to deliver health care at a distance in the allergy and immunology subspecialty.

The researchers note that telemedicine allows increased access to care and could lead to improved health outcomes, reductions in medical costs, enhanced use of resources, expanded opportunities for education, and improved collaboration between physicians and patients. These potential benefits of telemedicine should be weighed against the associated challenges and risks, including issues relating to prescribing and licensing, disruption of the continuity of care between patients and physicians, depersonalization of the patient-physician relationship, and regulatory concerns associated with technology and reimbursement as well as security concerns and certain legal barriers.

"The American College of Allergy, Asthma & Immunology will also need to monitor this rapidly changing landscape to ensure provision of high-quality care to the patient with allergic and immunologic disorders and consistency of practice in an era of futuristic technologies," the authors write. "Despite the challenges, the current and future benefits of telemedicine are promising and exciting for allergists, patients, and health care systems."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »